CAS: 249937-52-8
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | Ro-3201195 REF: 54-BUP12439CAS: 249937-52-8 | ≥98% | 1,096.00 €~4,703.00 € | Wed 30 Apr 25 |
 | Ro-3201195 REF: TM-T68134CAS: 249937-52-8 | 100% | 128.00 €~2,812.00 € | Wed 30 Apr 25 |
Ref: 54-BUP12439
| 1g | 4,703.00 € | ||
| 25mg | 1,096.00 € | ||
| 50mg | 1,390.00 € | ||
| 100mg | 1,904.00 € | ||
| 500mg | 3,807.00 € |
Estimated delivery in United States, on Wednesday 30 Apr 2025
Ro-3201195
CAS:249937-52-8
Ro-3201195 is a novel orally available p38 MAPK inhibitor with high selectivity.
Formula:
C19H18FN3O4
Purity:
100%
Color and Shape:
Liquid
Molecular weight:
371.36
Ref: TM-T68134
| 1mg | 128.00 € | ||
| 5mg | 304.00 € | ||
| 10mg | 457.00 € | ||
| 25mg | 747.00 € | ||
| 50mg | 1,026.00 € | ||
| 100mg | 1,406.00 € | ||
| 500mg | 2,812.00 € |
Estimated delivery in United States, on Wednesday 30 Apr 2025
